Schimmelpennink Evert B. (CIK 1713795) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-30). Recent activity: Buy LENZ (28,089 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | LENZ Therapeutics, Inc. (LENZ) | President, CEO and Secretary | Buy | 28,089 | $251,397 |
来源：SEC Form 4 申报文件 · 截至 2026-03-30